An innovative project of Mount Sinai Medical Center in New York City, HepCure is improving provider knowledge & patient engagement for chronic disease management in persons infected with the Hepatitis C Virus (HCV). The toolkit is designed to address barriers for the effective care and treatment of HCV by providing web-based and smartphone enabled resources, navigation, consultation, and support for both patients and providers. The HepCure toolkit draws upon the experience of expert providers within the Mount Sinai Network, with support and development by Sinai AppLab, Mount Sinai Medical Center. HepCure was developed by the Mount Sinai Division of Liver Diseases, Division of General Internal Medicine, and the Informatics for Research, Outcomes, and Quality initiative in the Division of Gastroenterology.
HepCure is a secure, cloud-based provider portal meant to virtually navigate providers through hepatitis C virus (HCV) care. The HepCure dashboard integrates tools to more effectively manage HCV infected patients. A flexible, scalable platform, the HepCure Dashboard provides a seamless flow of information within a digital healthcare infrastructure. HepCure enables easy access to HCV resources and best-practices for optimal management of HCV patients with the opportunity to engage patients on treatment, while improving overall health outcomes. The platform serves as an organizational tool, with built-in workflow efficiencies that optimize treatment decisions, reduce redundancies, as well as promote provider training and development.
Through the use of the dashboard and patient app, providers can:
We at HepCure are always looking for ways to improve. That’s why we’re constantly working on new features and meeting new challenges! Here are just a few of the features we plan to explore:
The patient app is a free resource for patients with hepatitis C, which allows them to track medication adherence, symptoms, and gain access to resources. It is available to download for free on iOS (App Store) and Android (Google Play) operating systems. While the app can be used by patients independently from the dashboard, it can also be linked with the provider dashboard. Providers can push lab data to patients and track treatment adherence and symptom data input by patients in real time.
The HepCure Tele-Education Webinar Series features many diverse and salient topics in hepatitis C. Each week, the webinar series showcases different speakers who are prominent members of the hepatitis C community. Our webinars are attended by a wide audience, and include providers, patient navigators, and other health workers from around the globe. Our collaboration with the New York State Clinical Education Initiative (CEI) and Empire Liver Foundation (ELF) allows us to provide continuing education credits (CME/CNE) through attendance to our webinars on the first and last Tuesday of every month.
All webinars are held on Tuesdays from 4:30 - 5:30pm EST
Please join us on Tuesday, May 21st at 4:30 PM EST for a presentation by Dr. David Wolf of New York Medical College. Dr. Wolf will present on:
“EASL 2019 Update”
David C. Wolf, MD, is a Professor of Clinical Medicine in the Department of Medicine, Division of Gastroenterology and Hepatobiliary Diseases at New York Medical College in Valhalla, NY. Previously, he served on the faculties at the University of Cincinnati and the Mount Sinai School of Medicine. In 1996, he established the Liver Transplant Program at Westchester Medical Center, where he continues to serve as its Medical Director.
Dr. Wolf received his undergraduate degree from Yale University and his medical degree from Columbia University College of Physicians and Surgeons. He completed a residency in Internal Medicine at Columbia Presbyterian Medical Center in New York and a clinical and research fellowship in Gastroenterology-Hepatology at Albert Einstein College of Medicine. Dr. Wolf is a board certified Internist, Gastroenterologist, and Transplant Hepatologist. He has published more than one hundred papers and abstracts on topics including autoimmune hepatitis, portal hypertension, liver cancer and the economics of liver transplant.
On Tuesday, May 14th at 4:30 PM EST, Ashley Zuppelli, PharmD, BCACP, AAHIVP, of Trillium Health presented on: “Improving Access by Utilizing the Pharmacist through Collaborative Drug Therapy Management (CDTM)”
Ashley received her PharmD from University at Buffalo, School of Pharmacy and completed her PGY-1 Pharmacy Practice residency at Erie County Medical Center in Buffalo, New York. She is a credentialed pharmacist by the American Academy of HIV Medicine and is certified by the Board of Pharmacy Specialties in Ambulatory Care. She is a core member of Monroe County Partnering to End the HIV Epidemic, also known as MCPEtE, and is a member of the NYS Hepatitis C Elimination Task Force. She is an Adjunct Professor of Pharmacy Practice at Wegman’s School of Pharmacy at St. John Fisher College and serves as a preceptor for pharmacy students from St. John Fisher, University at Buffalo and D’Youville College. Ashley serves as the Director of Innovation Services at Trillium Health and oversees the Hepatitis C and Pre- and Post-Exposure Prophylaxis Programs. She was recognized by Rochester Business Journal as a 2018 40 Under 40 honoree. Ashley is also certified in New York State to provide patient care through collaborative drug therapy management and administer immunizations.
These learning modules are intended for clinicians of all backgrounds who may encounter or treat patients with hepatitis C and would like to establish core competencies in screening & diagnosis, evaluation and management of the disease. Content includes screening and linkage to care, initial evaluation, diagnosis and recognition of clinical manifestations. These modules were originally presented as a component of the HepCure Tele-Education Webinar Series.
These learning modules are intended for clinicians who have experience treating patients with hepatitis C and would like to further their knowledge. These modules were originally presented as a component of the HepCure Tele-Education Webinar Series.
Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment
THe Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment (PREP-C) is a free interactive online tool that enables you to provide a thorough assessment of a patient’s psychosocial readiness to begin Hepatitis C treatment, and make a treatment plan to improve treatment readiness.
This free online tool can be used by any type of professional involved in preparing a patient for Hepatitis C Treatment including medical providers, nurses, mental health, substance use, social work, pharmacy, case management, treatment adherence and health education specialists.